Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Digene Corporation logo — Innovative, reliable gene-based diagnostic solutions targeti...

Digene Corporation

Innovative, reliable gene-based diagnostic solutions targeting women's cancers and infectious diseases worldwide.

Founded 1987 36 employees Post Ipo Equity Total: $103.50M Biotechnology, Manufacturing

General Information

Company Name Digene Corporation
Founded Year 1987
Founders / Decision Makers
Floyd Taub, M.D. Taub — Founder
Employees 36
Industries Biotechnology, Manufacturing
Funding Stage Post Ipo Equity
Social

Get notified when Digene Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Digene Corporation

Digene Corporation is a biotechnology and manufacturing company that focuses on developing, manufacturing, and marketing proprietary gene-based diagnostic tests for screening, monitoring, and diagnosing human diseases, particularly women’s cancers and infectious diseases worldwide. Established in 1987, the company's flagship product, The Digene HPV Test, is an FDA-approved diagnostic tool specifically designed to detect human papillomavirus (HPV), a significant cause of cervical cancer. The company received a notable $84.00M Post-IPO Equity investment on 17 November 2005. With its innovative and reliable solutions, Digene Corporation is making impactful strides in pushing the boundaries of gene-based diagnostics.

Taxonomy: gene-based diagnostic solutions, women's cancers, infectious diseases, global healthcare, proprietary diagnostic tests, HPV testing, cervical cancer screening, FDA-approved, health technology, disease monitoring, diagnostic tools, oncology diagnostics, precision medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $84.00M - 17 Nov 2005
Post-IPO Equity $19.50M - 17 Jan 2000

Digene Corporation Alternatives & Competitors

Digene Corporation vs
IncellDx
IncellDx United States

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a ti...

Series Unknown
23 employees
Biotechnology, Health Care
Compare Digene Corporation vs IncellDx
Digene Corporation vs
Geneoscopy
Geneoscopy United States

Cancer Prevention | Diagnostics | Precision Medicine

Series B
60 employees
Biotechnology, Health Care
Compare Digene Corporation vs Geneoscopy
Digene Corporation vs
Iverson Genetic Diagnostics
Iverson Genetic Diagnostics

Your partner in diagnosing and treating chronic diseases, offering advanced genetic tests for precis...

Debt Financing
Biotechnology, Health Care
Compare Digene Corporation vs Iverson Genetic Diagnostics

FAQ About Digene Corporation

Innovative, reliable gene-based diagnostic solutions targeting women's cancers and infectious diseases worldwide.
Digene Corporation was founded in 1987.
Digene Corporation operates in the following industries: Biotechnology, Manufacturing.
Digene Corporation has approximately 36 employees.
Digene Corporation has completed 2 funding rounds, raising a total of $103.50M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Digene Corporation include IncellDx, Geneoscopy, Iverson Genetic Diagnostics, Self-screen B.V., ImunoTera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Digene Corporation and IncellDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Digene Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy